PCOS and Hyperprolactinemia: Conflicting Conditions or Comorbidities?
Currently, hyperprolactinemia is considered as a condition to be excluded during the diagnosis of polycystic ovarian syndrome (PCOS), because it often demonstrates clinical signs similar to PCOS. However, some publications have reported “the prevalence of hyperprolactinemia in PCOS,” which does not...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
International Medical Research and Development Corporation
2021-12-01
|
Series: | International Journal of Biomedicine |
Subjects: | |
Online Access: | http://ijbm.org/articles/i44/ijbm_11(4)_br1.pdf |
_version_ | 1819004060543483904 |
---|---|
author | Alina V. Atalyan Eldar M. Sharifulin Lyudmila M. Lazareva Yana G. Nadelyaeva Larisa V. Suturina |
author_facet | Alina V. Atalyan Eldar M. Sharifulin Lyudmila M. Lazareva Yana G. Nadelyaeva Larisa V. Suturina |
author_sort | Alina V. Atalyan |
collection | DOAJ |
description | Currently, hyperprolactinemia is considered as a condition to be excluded during the diagnosis of polycystic ovarian syndrome (PCOS), because it often demonstrates clinical signs similar to PCOS. However, some publications have reported “the prevalence of hyperprolactinemia in PCOS,” which does not agree with the statement above statement. The publications presented in this review demonstrate conflicting approaches to considering the association of hyperprolactinemia and PCOS. On the one hand, the current consensus on the diagnosis of PCOS assumes the exclusion of patients with hyperprolactinemia, and on the other hand, some authors consider hyperprolactinemia as an acceptable condition and estimate its prevalence in PCOS. Based on the analysis of the literature, we have demonstrated a contradictory attitude towards the association between hyperprolactinemia and PCOS. To overcome the contradiction, we consider it appropriate to use the term "potential PCOS" before the final assessment of the contribution of hyperprolactinemia to the development of symptoms similar to PCOS. The final diagnosis of PCOS in the presence of hyperprolactinemia is possible only after its correction and reassessment of all symptoms. |
first_indexed | 2024-12-20T23:30:53Z |
format | Article |
id | doaj.art-0221e55ad80f4786b783bb13dc0d8cae |
institution | Directory Open Access Journal |
issn | 2158-0510 2158-0529 |
language | English |
last_indexed | 2024-12-20T23:30:53Z |
publishDate | 2021-12-01 |
publisher | International Medical Research and Development Corporation |
record_format | Article |
series | International Journal of Biomedicine |
spelling | doaj.art-0221e55ad80f4786b783bb13dc0d8cae2022-12-21T19:23:17ZengInternational Medical Research and Development CorporationInternational Journal of Biomedicine2158-05102158-05292021-12-0111448048310.21103/Article11(4)_BR1PCOS and Hyperprolactinemia: Conflicting Conditions or Comorbidities?Alina V. Atalyan0Eldar M. Sharifulin1Lyudmila M. Lazareva2Yana G. Nadelyaeva3Larisa V. Suturina4Scientific Centre for Family Health and Human Reproduction Problems, Irkutsk, the Russian FederationScientific Centre for Family Health and Human Reproduction Problems, Irkutsk, the Russian FederationScientific Centre for Family Health and Human Reproduction Problems, Irkutsk, the Russian FederationScientific Centre for Family Health and Human Reproduction Problems, Irkutsk, the Russian FederationScientific Centre for Family Health and Human Reproduction Problems, Irkutsk, the Russian FederationCurrently, hyperprolactinemia is considered as a condition to be excluded during the diagnosis of polycystic ovarian syndrome (PCOS), because it often demonstrates clinical signs similar to PCOS. However, some publications have reported “the prevalence of hyperprolactinemia in PCOS,” which does not agree with the statement above statement. The publications presented in this review demonstrate conflicting approaches to considering the association of hyperprolactinemia and PCOS. On the one hand, the current consensus on the diagnosis of PCOS assumes the exclusion of patients with hyperprolactinemia, and on the other hand, some authors consider hyperprolactinemia as an acceptable condition and estimate its prevalence in PCOS. Based on the analysis of the literature, we have demonstrated a contradictory attitude towards the association between hyperprolactinemia and PCOS. To overcome the contradiction, we consider it appropriate to use the term "potential PCOS" before the final assessment of the contribution of hyperprolactinemia to the development of symptoms similar to PCOS. The final diagnosis of PCOS in the presence of hyperprolactinemia is possible only after its correction and reassessment of all symptoms.http://ijbm.org/articles/i44/ijbm_11(4)_br1.pdfmacroprolactinemiapolycystic ovarian syndromehyperandrogenismhirsutism |
spellingShingle | Alina V. Atalyan Eldar M. Sharifulin Lyudmila M. Lazareva Yana G. Nadelyaeva Larisa V. Suturina PCOS and Hyperprolactinemia: Conflicting Conditions or Comorbidities? International Journal of Biomedicine macroprolactinemia polycystic ovarian syndrome hyperandrogenism hirsutism |
title | PCOS and Hyperprolactinemia: Conflicting Conditions or Comorbidities? |
title_full | PCOS and Hyperprolactinemia: Conflicting Conditions or Comorbidities? |
title_fullStr | PCOS and Hyperprolactinemia: Conflicting Conditions or Comorbidities? |
title_full_unstemmed | PCOS and Hyperprolactinemia: Conflicting Conditions or Comorbidities? |
title_short | PCOS and Hyperprolactinemia: Conflicting Conditions or Comorbidities? |
title_sort | pcos and hyperprolactinemia conflicting conditions or comorbidities |
topic | macroprolactinemia polycystic ovarian syndrome hyperandrogenism hirsutism |
url | http://ijbm.org/articles/i44/ijbm_11(4)_br1.pdf |
work_keys_str_mv | AT alinavatalyan pcosandhyperprolactinemiaconflictingconditionsorcomorbidities AT eldarmsharifulin pcosandhyperprolactinemiaconflictingconditionsorcomorbidities AT lyudmilamlazareva pcosandhyperprolactinemiaconflictingconditionsorcomorbidities AT yanagnadelyaeva pcosandhyperprolactinemiaconflictingconditionsorcomorbidities AT larisavsuturina pcosandhyperprolactinemiaconflictingconditionsorcomorbidities |